Alaa Embaby

In December 2019, I joined the group of Jos Beijnen as a PhD student. My projects consist of phase I clinical studies in patients with advanced solid tumors. With several investigational drugs (targeted therapies), we hope to achieve higher response rates and longer progression free intervals in this patient population.